Erratum: Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy (Journal of Medicinal Chemistry (2011) 54 (782-787) DOI: 10.1021/jm101018r);Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy

Journal of Medicinal Chemistry

Volumn 54, Issue 3, 2011, Pages 782-787

  Akcan, Muharrem ^a   Stroud, Mark R ^b   Hansen, Stacey J ^b   Clark, Richard J ^a   Daly, Norelle L ^a   Craik, David J ^a   Olson, James M ^b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; CHLOROTOXIN; LYSINE; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ENGINEERING; CLINICAL TRIAL; HUMAN; MOLECULARLY TARGETED THERAPY; PLASMA HALF LIFE;

EID: 79851505305     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4016119     Document Type: Erratum

References (31)

1. Veiseh, M.; Gabikian, P.; Bahrami, S. B.; Veiseh, O.; Zhang, M.; Hackman, R. C.; Ravanpay, A. C.; Stroud, M. R.; Kusuma, Y.; Hansen, S. J.; Kwok, D.; Munoz, N. M.; Sze, R. W.; Grady, W. M.; Greenberg,N. M.; Ellenbogen, R. G.; Olson, J. M. Tumor paint:A chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007, 67, 6882-6888. (Pubitemid 47105535)
2. Veiseh, O.; Sun, C.; Gunn, J.; Kohler, N.; Gabikian, P.; Lee, D.; Bhattarai, N.; Ellenbogen, R.; Sze, R.; Hallahan, A.; Olson, J.; Zhang, M. Q. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005, 5, 1003-1008. (Pubitemid 40925409)
3. Soroceanu, L.; Gillespie, Y.; Khazaeli, M. B.; Sontheimer, H. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res. 1998, 58, 4871-4879. (Pubitemid 28503684)
4. Lyons, S. A.; O'Neal, J.; Sontheimer, H. Chlorotoxin, a scorpionderived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 2002, 39, 162-173. (Pubitemid 34817056)
5. DeBin, J. A.; Strichartz, G. R. Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus. Toxicon 1991, 29, 1403-1408.
6. DeBin, J. A.; Maggio, J. E.; Strichartz, G. R. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am. J. Physiol. Cell Physiol. 1993, 264, C361-369. (Pubitemid 23072445)
7. Lippens, G.; Najib, J.; Wodak, S. J.; Tartar, A. NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. Biochemistry 1995, 34, 13-21.
8. Clark, R. J.; Fischer, H.; Dempster, L.; Daly, N. L.; Rosengren, K. J.; Nevin, S. T.; Meunier, F. A.; Adams, D. J.; Craik, D. J. Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the alpha-conotoxin MII. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 13767-13772. (Pubitemid 41377653)
9. Lovelace, E. S.; Armishaw, C. J.; Colgrave, M. L.; Wahlstrom, M. E.; Alewood, P. F.; Daly, N. L.; Craik, D. J. Cyclic MrIA: A stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter. J. Med. Chem. 2006, 49, 6561-6568. (Pubitemid 44657450)
10. Armishaw, C. J.; Dutton, J. L.; Craik, D. J.; Alewood, P. F. Establishing regiocontrol of disulfide bond isomers of alphaconotoxin ImI via the synthesis ofN-to-Ccyclic analogs. Biopolymers 2010, 94, 307-313.
11. Clark, R. J.; Jensen, J.; Nevin, S. T.; Callaghan, B. P.; Adams, D. J.; Craik, D. J. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew. Chem., Int. Ed. 2010, 49, 6545-6548.
12. Swedberg, J. E.; Nigon, L. V.; Reid, J. C.; de Veer, S. J.; Walpole, C. M.; Stephens,C.R.; Walsh,T. P.;Takayama, T.K.;Hooper, J. D.; Clements, J. A.;Buckle, A.M.;Harris, J. M. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. Chem. Biol. 2009, 16, 633-643.
13. Schnolzer, M.; Alewood, P.; Jones, A.; Alewood, D.; Kent, S. B. H. In situ neutralization in boc-chemistry solid phase peptide synthesis - Rapid, high yield assembly of difficult sequences. Int. J. Pept. Res. Ther. 2007, 13, 31-44. (Pubitemid 46888447)
14. Clark, R. J.; Jensen, J.; Nevin, S. T.; Callaghan, B. P.; Adams, D. J.; Craik, D. J. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew. Chem., Int. Ed. 2010, 49, 6545-6548.
15. Dawson, P. E.; Muir, T. W.; Clarklewis, I.; Kent, S. B. H. Synthesis of proteins by native chemical ligation. Science 1994, 266, 776-779. (Pubitemid 24359280)
16. Tam, J. P.; Lu, Y.-A.; Yu, Q. Thia Zip reaction for synthesis of large cyclic peptides: mechanisms and applications. J. Am. Chem. Soc. 1999, 121, 4316-4324.
17. Camarero, J. A.; Muir, T. W. Chemoselective backbone cyclization of unprotected peptides. Chem. Commun. 1997, 1369-1370. (Pubitemid 127496034)
18. Camarero, J. A.; Pavel, J.; Muir, T. W. Chemical synthesis of a circular protein domain: Evidence for folding-assisted cyclization. Angew. Chem., Int. Ed. 1998, 37, 347-349.
19. Wuthrich, K. NMR of Proteins and Nucleic Acids; Wiley-Interscience: New York, 1986.
20. Walk, E. E. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare. Curr. Opin. Drug Discovery Dev. 2010, 13, 226-234.
21. Hait, W. N. - Anticancer drug development: The grand challenges. Nat. Rev. Drug Discovery 2010, 9, 253-254.
22. Greenwood, K. P.; Daly, N. L.; Brown, D. L.; Stow, J. L.; Craik, D. J. The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 2007, 39, 2252-2264. (Pubitemid 47484280)
23. Herrmann, A.; Svangard, E.; Claeson, P.; Gullbo, J.; Bohlin, L.; Goransson, U. Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell. Mol. Life Sci. 2006, 63, 235-245. (Pubitemid 43100292)
24. Deshane, J.; Garner, C. C.; Sontheimer, H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. 2003, 278, 4135-4144. (Pubitemid 36801150)
25. Yeatman, T. J.; Updyke, T. V.; Kaetzel, M. A.; Dedman, J. R.; Nicolson, G. L. Expression of annexins on the surfaces of nonmetastatic and metastatic human and rodent tumor cells. Clin. Exp. Metastasis 1993, 11, 37-44. (Pubitemid 23045688)
26. Kesavan, K.; Ratliff, J.; Johnson, E. W.; Dahlberg, W.; Asara, J. M.; Misra, P.; Frangioni, J. V.; Jacoby, D. B. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J. Biol. Chem. 2010, 285, 4366-4374.
27. Daly, N. L.; Rosengren, K. J.; Craik, D. J. Discovery, structure and biological activities of cyclotides. Adv. Drug Delivery Rev. 2009, 61, 918-930.
28. Sancheti, H.; Camarero, J. A. "Splicing up" drug discovery. Cellbased expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides. Adv. Drug Delivery Rev. 2009, 61, 908-917.
29. Hallahan, A. R.; Pritchard, J. I.; Hansen, S.; Benson,M.; Stoeck, J.; Hatton, B. A.; Russell, T. L.; Ellenbogen, R. G.; Bernstein, I. D.; Beachy, P. A.; Olson, J. M. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehoginduced medulloblastomas. Cancer Res. 2004, 64, 7794-7800. (Pubitemid 39446912)
30. Hatton, B. A.; Villavicencio, E. H.; Tsuchiya, K. D.; Pritchard, J. I.; Ditzler, S.; Pullar, B.; Hansen, S.; Knoblaugh, S. E.; Lee, D.; Eberhart, C. G.; Hallahan, A. R.; Olson, J. M. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res. 2008, 68, 1768-1776. (Pubitemid 351416562)
31. Wishart, D. S.; Bigam, C. G.; Yao, J.; Abildgaard, F.; Dyson, H. J.; Oldfield, E.; Markley, J. L.; Sykes, B. D. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 1995, 6, 135-140.